 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing and commercializing peptide therapeutics for the treatment of gastrointestinal diseases and genetic deficiencies. The firm focuses on the treatment for Prader-Willi Syndrome and Pro-Opiomelanocortin deficiency obesity. Its product candidate includes setmelanotide, an MC4R agonist designed to restore impaired MC4R pathway function caused by genetic variants that occur upstream of the MC4R. The company was founded by Bart Henderson in November 2008 and is headquartered in Boston, MA.

Current Price	$17.36
Prev Close	$17.85
Open	$17.86
Dividend Yield	0.00%
50-Day Moving Average	$18.05
Beta	1.34
Avg. Volume	722,499.23
PE Ratio	-5.31

52-Week High	$34.99
52-Week Low	$3.14
Market Capitalization	$1.01B
EPS	-$3.36
Price to Book	4.62
Revenue Per Employee	$189,881.36
Enterprise Value/EBITDA	-4.49

RYTM Rhythm Pharmaceuticals Inc.

About

Feed

Fundamentals

News